Market Cap 598.34M
Revenue (ttm) 266.27M
Net Income (ttm) -50.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.94%
Debt to Equity Ratio -18.46
Volume 1,393,400
Avg Vol 1,003,846
Day's Range N/A - N/A
Shares Out 64.48M
Stochastic %K 21%
Beta 0.97
Analysts Strong Sell
Price Target $24.17

Company Profile

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 949 284 4555
Address:
520 Newport Center Drive, Suite 1200, Newport Beach, United States
goofyfoot
goofyfoot Jul. 30 at 6:05 PM
$EOLS is going to announce earnings on Tuesday, August 5, after the market closes. A $0.098/share loss is expected, which is an improvement over last quarter’s $0.15/share loss.
0 · Reply
DJebay
DJebay Jul. 27 at 3:44 AM
$EOLS being shorted like crazy before earnings? So odd
1 · Reply
Allf2
Allf2 Jul. 26 at 1:27 AM
$EOLS It was a day of doubt about investing in this stock. In Korea, Botox plastic surgery to remove cheek fat was popular and is still ongoing due to v-line marketing. If there is a trend in the US that prefers sharp jaws someday, Botox treatment will be more popular. The market situation that is focused on getting rid of wrinkles is a bit frustrating. Even the market growth forecast has decreased!
0 · Reply
goofyfoot
goofyfoot Jul. 25 at 7:51 PM
$EOLS Strange moves today. The bottom almost fell out, followed by a quick recovery. Hmmm…
0 · Reply
Allf2
Allf2 Jul. 25 at 3:27 PM
$EOLS oooops
1 · Reply
EricKuoTW
EricKuoTW Jul. 24 at 6:06 PM
0 · Reply
DCRMIA
DCRMIA Jul. 24 at 1:45 PM
$EOLS much more is about to come
1 · Reply
Allf2
Allf2 Jul. 23 at 12:30 AM
$EOLS start
0 · Reply
goofyfoot
goofyfoot Jul. 17 at 11:14 PM
$EOLS $EOLS Let’s get this puppy cooking. The ER is the 30th, according to Yahoo!
0 · Reply
Mandi63
Mandi63 Jul. 15 at 1:44 PM
$AEON $CDLI $INKT $LENZ $AEON Next month $2-5 $EOLS EUROPEAN PARTNERS ALREADY SELLING THIS DRUG
0 · Reply
Latest News on EOLS
Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings

Jul 21, 2025, 5:20 PM EDT - 9 days ago

Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings


Evolysse™ Recognized in 2025 Shape Skin Awards

Jun 10, 2025, 8:00 AM EDT - 7 weeks ago

Evolysse™ Recognized in 2025 Shape Skin Awards


Evolus Announces Departure of its Chief Financial Officer

May 27, 2025, 4:15 PM EDT - 2 months ago

Evolus Announces Departure of its Chief Financial Officer


Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:13 PM EDT - 3 months ago

Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript


Evolus Reports First Quarter 2025 Results

May 7, 2025, 4:05 PM EDT - 3 months ago

Evolus Reports First Quarter 2025 Results


Evolus to Report First Quarter Financial Results on May 7, 2025

Apr 23, 2025, 8:00 AM EDT - 3 months ago

Evolus to Report First Quarter Financial Results on May 7, 2025


Evolus Announces Commercial Launch of Evolysse™

Apr 16, 2025, 8:00 AM EDT - 3 months ago

Evolus Announces Commercial Launch of Evolysse™


Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 11:18 PM EST - 5 months ago

Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript


US FDA approves Evolus' anti-wrinkle gels

Feb 13, 2025, 1:45 PM EST - 5 months ago

US FDA approves Evolus' anti-wrinkle gels


Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript

Nov 6, 2024, 7:28 PM EST - 9 months ago

Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript


Evolus Reports Third Quarter 2024 Results

Nov 6, 2024, 4:05 PM EST - 9 months ago

Evolus Reports Third Quarter 2024 Results


Evolus to Participate in Stifel 2024 Healthcare Conference

Nov 1, 2024, 8:00 AM EDT - 9 months ago

Evolus to Participate in Stifel 2024 Healthcare Conference


Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 10:22 PM EDT - 1 year ago

Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript


Evolus to Hold Investor Day on September 12, 2024

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Evolus to Hold Investor Day on September 12, 2024


Evolus: Chiseling Away At The Aesthetic Market

May 22, 2024, 7:00 AM EDT - 1 year ago

Evolus: Chiseling Away At The Aesthetic Market


Evolus, Inc. (EOLS) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:27 PM EDT - 1 year ago

Evolus, Inc. (EOLS) Q1 2024 Earnings Call Transcript


goofyfoot
goofyfoot Jul. 30 at 6:05 PM
$EOLS is going to announce earnings on Tuesday, August 5, after the market closes. A $0.098/share loss is expected, which is an improvement over last quarter’s $0.15/share loss.
0 · Reply
DJebay
DJebay Jul. 27 at 3:44 AM
$EOLS being shorted like crazy before earnings? So odd
1 · Reply
Allf2
Allf2 Jul. 26 at 1:27 AM
$EOLS It was a day of doubt about investing in this stock. In Korea, Botox plastic surgery to remove cheek fat was popular and is still ongoing due to v-line marketing. If there is a trend in the US that prefers sharp jaws someday, Botox treatment will be more popular. The market situation that is focused on getting rid of wrinkles is a bit frustrating. Even the market growth forecast has decreased!
0 · Reply
goofyfoot
goofyfoot Jul. 25 at 7:51 PM
$EOLS Strange moves today. The bottom almost fell out, followed by a quick recovery. Hmmm…
0 · Reply
Allf2
Allf2 Jul. 25 at 3:27 PM
$EOLS oooops
1 · Reply
EricKuoTW
EricKuoTW Jul. 24 at 6:06 PM
0 · Reply
DCRMIA
DCRMIA Jul. 24 at 1:45 PM
$EOLS much more is about to come
1 · Reply
Allf2
Allf2 Jul. 23 at 12:30 AM
$EOLS start
0 · Reply
goofyfoot
goofyfoot Jul. 17 at 11:14 PM
$EOLS $EOLS Let’s get this puppy cooking. The ER is the 30th, according to Yahoo!
0 · Reply
Mandi63
Mandi63 Jul. 15 at 1:44 PM
$AEON $CDLI $INKT $LENZ $AEON Next month $2-5 $EOLS EUROPEAN PARTNERS ALREADY SELLING THIS DRUG
0 · Reply
Mandi63
Mandi63 Jul. 10 at 1:14 PM
$AEON Slow move to $1-2 then when results announced $5-10 any shares needed to sale will be higher priced a less dilution…new CEO new VISION 25 years experience FDA UPCOMING IS BROAD DECISION EUROPEAN PARTNER $EOLS ALREADY SELLING THIS DRUG INSIDE BUYING SUPER LOW FLOAT ECT DO YOUR OWN RESEACH
0 · Reply
junebug67
junebug67 Jul. 9 at 3:27 PM
0 · Reply
junebug67
junebug67 Jul. 8 at 4:13 PM
0 · Reply
Mandi63
Mandi63 Jul. 2 at 8:13 AM
0 · Reply
DCRMIA
DCRMIA Jun. 28 at 11:06 PM
$EOLS is getting hot, and it's gonna blow up next week. You'll see.
0 · Reply
Mandi63
Mandi63 Jun. 25 at 12:21 PM
$AEON Already approved..drug..selling though international partner $EOLS FDA APPROVAL COMING…OR BUYOUT $10.00-25.00
0 · Reply
Olena
Olena Jun. 23 at 11:42 PM
$AEON $EOLS ready!
0 · Reply
Culby
Culby Jun. 17 at 2:28 PM
$EOLS what’s keeping this in this $9 range? Everytime it looks like it’s gonna start to move it gets stomped back down.
1 · Reply
Mandi63
Mandi63 Jun. 13 at 5:30 PM
$AEON LOOK FOR A STRONG CLOSE…HEADED FOR THE WEEKEND…FDA MEETING…DATA PRESENTED INSIDE BUYING…SHARES BEING LOCKED Up …JOREY CHERNETT BOUGHT 1,250,000 PLUS SHARE… THREE CONFIRMED 5% SHAREHOLDERS….ALREADY APPROVED DRUG BEING SOLD THOUGH INTERNATIONAL PARTNER $EOLS….LOOK FOR FAST-TRACK APPROVAL…
0 · Reply
Mandi63
Mandi63 Jun. 12 at 12:41 PM
$AEON ALREADY APPROVED DRUG…NATIONAL PARTNER $EOLS FDA MEETING COMING WITH DATA RESULTS SHAREHOLDER MEETING TOMORROW….$1.00 PLUS INSIDE BUYING NEW CEO WITH 25 YEARS EXPERIENCE INVOLVED WITH MERGER BUYOUT $10.00 PLUS
1 · Reply
Mandi63
Mandi63 Jun. 11 at 5:06 PM
$AEON Clearpath CEO JOREY Chernett bought. 10% of AEON.. Inside buying with last date 5/21 National Partner $EOLS $5.00-25.00 price target $360.00
0 · Reply
Rossumopossum
Rossumopossum Jun. 11 at 1:46 PM
$EOLS lets see this thing go today. Its overdue imo nfa
1 · Reply